Skip to content

Harlan S Robins, Chief Scientific Officer at Adaptive Biotechnologies, sold ADPT on Jul 21, 2026

Data as of Oct 16

▼ SELL$6.1M278,698 shares at $21.72Harlan S Robins Chief Scientific OfficerADPT Adaptive Biotechnologies Corp
Watch ADPT
Traded
Jul 21, 2026
Disclosed
Jul 23, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Harlan S Robins, Chief Scientific Officer at Adaptive Biotechnologies, sold ADPT on Jul 21, 2026TRADEDDISCLOSED
ADPTSimilar stocks (XLV — its sector index fund), rebased to ADPT's price on the disclosure day
ADPT since disclosure
+7.7%
after the sale
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund

Change in closing price from Jul 23, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHarlan S Robins Chief Scientific OfficerADPT Adaptive Biotechnologies Corp$4.7Mdisclosed Jul 23 · filed 2 days after the trade

See every trade on ADPT →